Sign in to view content

Efficacy and Safety Outcomes Over 12 Weeks With OCS-01 Eye Drops in DME From DIAMOND-Stage 1 Trial:Focus on Subgroup by Prior Treatment Status

Baruch D. Kuppermann, MD, PhD

Video
Published 2025

Related

Episode 10: Cytokines Levels and Response to Ranibizumab in DME with Dr. Rajeev Muni
Keyvan Koushan, MD, FRCSC
Member Podcasts
2018
A Phase I Study to Evaluate the Tie2 Agonist RO7446603, Alone or in Combination With Aflibercept orFaricimab, in Diabetic Macular Edema
Jeremiah Brown, MD, MS, FASRS
Annual Meeting Talks
2025
A Randomized Trial Comparing Suprachoroidal Injection of Triamcinolone and Intravitreal Dexamethasone Implant for Refractory Diabetic Macular Edema
Murat Oncel, MD, FASRS
Annual Meeting Talks
2024

Category: Retinal Vascular Disease

See more